Revealed: How Ireland has worst access for new cancer drugs
The situation impacts public patients and those with private health insurance as health insurers do not typically fund or provide access to medicines that are not funded by the HSE.
Irish cancer patients are being denied access to innovative new medicines that are often available in other EU countries.
Independent journalism every day
With digital access you can read The Business Post whenever, wherever, and however you want.
- Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
- Breaking news, comment and analysis from the best Business Post writers seven days a week.
- Live blogs of major news events
- Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
- Access to The Business Post's extensive archive
